XML 51 R4.htm IDEA: XBRL DOCUMENT v3.20.1
Consolidated Statements of Operations (Unaudited) - USD ($)
 3 Months Ended 9 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Mar. 31, 2020
Mar. 31, 2019
Revenues        
Total revenue $ 8,156,173 $ 2,377,792 $ 12,771,235 $ 5,604,612
Operating expenses        
Cost of sales 1,998,659 616,853 2,980,425 1,552,950
Research and development 78,502 108,901 223,197 413,808
Selling, general and administrative 9,501,469 5,368,762 21,164,072 13,991,516
Selling, general and administrative - related party 0 6,797 0 351,843
Amortization of intangible assets 1,370,986 575,117 2,899,553 1,561,137
Total operating expenses 12,949,616 6,676,430 27,267,247 17,871,254
Loss from operations (4,793,443) (4,298,638) (14,496,012) (12,266,642)
Other (expense) income        
Other (expense), net (538,862) (194,703) (1,181,206) (398,833)
Gain from derecognition of contingent consideration 0 0 5,199,806 0
Gain from warrant derivative liability 0 (2,521) 1,830 65,468
Total other (expense) income (538,862) (197,224) 4,020,430 (333,365)
Net loss $ (5,332,305) $ (4,495,862) $ (10,475,582) $ (12,600,007)
Weighted average number of common shares outstanding 35,275,296 9,061,023 22,616,962 5,785,669
Basic and diluted net loss per common share $ (0.15) $ (0.50) $ (0.46) $ (2.18)
Product Revenue        
Revenues        
Total revenue $ 8,156,173 $ 2,372,016 $ 12,771,235 $ 5,598,836
License Revenue        
Revenues        
Total revenue $ 0 $ 5,776 $ 0 $ 5,776